+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Vaccine Adjuvant"

Recombinant Vaccines Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Recombinant Vaccines Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Vaccines Companies in China - Product Thumbnail Image

Vaccines Companies in China

  • Report
  • July 2024
  • 90 Pages
  • China
From
Vaccines Markets in China - Product Thumbnail Image

Vaccines Markets in China

  • Report
  • July 2024
  • 326 Pages
  • China
From
Drug Overview: V180 - Product Thumbnail Image

Drug Overview: V180

  • Drug Pipelines
  • January 2018
  • 13 Pages
  • Global
From
From
U.S. Vaccines Market: Opportunity Analysis and Industry Forecast, 2024-2033 - Product Thumbnail Image

U.S. Vaccines Market: Opportunity Analysis and Industry Forecast, 2024-2033

  • Report
  • December 2024
  • 90 Pages
  • United States
From
UK Vaccines Market: Opportunity Analysis and Industry Forecast, 2024-2033 - Product Thumbnail Image

UK Vaccines Market: Opportunity Analysis and Industry Forecast, 2024-2033

  • Report
  • November 2024
  • 150 Pages
  • United Kingdom
From
From
Loading Indicator

The Vaccine Adjuvant market is a subset of the Vaccines market, which is composed of products that are used to enhance the effectiveness of vaccines. Vaccine adjuvants are substances that are added to vaccines to increase the body's immune response to the vaccine. Adjuvants can be either natural or synthetic, and can be used to increase the potency of a vaccine, reduce the amount of antigen needed, or to extend the duration of the vaccine's effectiveness. Vaccine adjuvants are used in a variety of vaccines, including those for influenza, hepatitis, and human papillomavirus. Some companies in the Vaccine Adjuvant market include GlaxoSmithKline, Merck, Sanofi, and Novartis. Show Less Read more